Search research articles
Contact Us
Filters
Showing results (71-80 of 108) with videos related to
Page
of 11
Sort By:
Brain Research
|
March 20, 1999
Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders
R P Copp, T Wisniewski, F Hentati, et al.
The American Journal of Pathology
|
February 1, 1992
Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions
T Iwaki, T Wisniewski, A Iwaki, et al.
The American Journal of Pathology
|
August 1, 1997
Presenilin-1 is associated with Alzheimer's disease amyloid
T Wisniewski, W K Dowjat, B Permanne, et al.
The Biochemical Journal
|
July 1, 1993
The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex
J Ghiso, E Matsubara, A Koudinov, et al.
Scientific Reports
|
March 3, 2017
De novo [PSI <sup>+</sup>] prion formation involves multiple pathways to form infectious oligomers
Jaya Sharma, Brett T Wisniewski, Emily Paulson, et al.
The American Journal of Pathology
|
April 18, 1998
Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy
V Askanas, W K Engel, C C Yang, et al.
Plos Genetics
|
October 3, 2024
The middle domain of Hsp104 can ensure substrates are functional after processing
Hannah E Buchholz, Jane E Dorweiler, Sam Guereca, et al.
American Journal of Ophthalmology
|
May 15, 1993
Gelsolin immunoreactivity in corneal amyloid, wound healing, and macular and granular dystrophies
M M Rodrigues, S Rajagopalan, K Jones, et al.
Neurobiology of Disease
|
February 1, 1996
Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation
C A Lemere, J K Blusztajn, H Yamaguchi, et al.
Current Genetics
|
September 1, 2017
Toxicity and infectivity: insights from de novo prion formation
Brett T Wisniewski, Jaya Sharma, Emily R Legan, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 108) with videos related to
Sort By:
Page
of 11
Brain Research
|
March 20, 1999
Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders
R P Copp, T Wisniewski, F Hentati, et al.
The American Journal of Pathology
|
February 1, 1992
Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions
T Iwaki, T Wisniewski, A Iwaki, et al.
The American Journal of Pathology
|
August 1, 1997
Presenilin-1 is associated with Alzheimer's disease amyloid
T Wisniewski, W K Dowjat, B Permanne, et al.
The Biochemical Journal
|
July 1, 1993
The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex
J Ghiso, E Matsubara, A Koudinov, et al.
Scientific Reports
|
March 3, 2017
De novo [PSI <sup>+</sup>] prion formation involves multiple pathways to form infectious oligomers
Jaya Sharma, Brett T Wisniewski, Emily Paulson, et al.
The American Journal of Pathology
|
April 18, 1998
Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy
V Askanas, W K Engel, C C Yang, et al.
Plos Genetics
|
October 3, 2024
The middle domain of Hsp104 can ensure substrates are functional after processing
Hannah E Buchholz, Jane E Dorweiler, Sam Guereca, et al.
American Journal of Ophthalmology
|
May 15, 1993
Gelsolin immunoreactivity in corneal amyloid, wound healing, and macular and granular dystrophies
M M Rodrigues, S Rajagopalan, K Jones, et al.
Neurobiology of Disease
|
February 1, 1996
Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation
C A Lemere, J K Blusztajn, H Yamaguchi, et al.
Current Genetics
|
September 1, 2017
Toxicity and infectivity: insights from de novo prion formation
Brett T Wisniewski, Jaya Sharma, Emily R Legan, et al.
Page
of 11